Drug intelligence / Profile preview

JUVÉDERM VOLLURE XC

Development stage
Unknown
Lead developer
Allergan
Modality
Small Molecules
Administration
Intradermal
01

Overview

JUVÉDERM VOLLURE XC is a sterile, biodegradable, non-pyrogenic, viscoelastic injectable gel implant composed of cross-linked hyaluronic acid (HA) produced by Streptococcus species bacteria and formulated with 0.3% lidocaine to reduce injection pain. It is indicated for injection into the mid-to-deep dermis for the correction of moderate to severe facial wrinkles and folds—such as nasolabial folds—in adults over 21 years old. The mechanism of action involves HA acting as a temporary filler that restores volume and smooths facial lines by attracting water molecules in the skin[1][6][8]. Lidocaine acts locally to decrease discomfort during administration[1][8]. Developed for subtle volume addition and natural-looking results, it provides long-lasting effects with minimal swelling or bruising[9].

Brand names
JUVÉDERM VOLLURE XC
Other names
Juvederm VollureJuvederm Vollure with Lidocaine
02

Targets

CD44 (CD44 antigen)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on JUVÉDERM VOLLURE XC.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on JUVÉDERM VOLLURE XC.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call